Evidence map›Paper›PMID 36427341›Full record

ArticleJournal of managed care & specialty pharmacy2022

Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.

Kristin A Evans, Michael Pollack, Edward Portillo, Charlie Strange, Daniel R Touchette, Anthony Staresinic, Sushma Patel, Joseph Tkacz, Norbert Feigler

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Prompt versus Delayed Triple Therapy in COPD: Solutions to Time-Related Biases in Observational Studies.International journal of chronic obstructive pulmonary disease · 2025
    Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Kristin A EvansReal World Data Research and Analytics, Merative, Ann Arbor, MI.
Michael PollackBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE.
Edward PortilloPharmacy Practice Division, University of Wisconsin-Madison School of Pharmacy.
Charlie StrangeDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston.
Daniel R TouchetteCenter for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois College of Pharmacy, Chicago.
Anthony StaresinicBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE.
Sushma PatelBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE.
Joseph TkaczLife Sciences, IBM Watson Health, Cambridge, MA, now with Inovalon, Washington DC.
Norbert FeiglerBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE.
AstraZeneca (Switzerland) · CHAmerican Pharmacists Association · USDiagnostics for the Real World (United Kingdom) · GBIBM Research - Thomas J. Watson Research Center · USMedical University of South Carolina · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AftercarePulmonary Disease, Chronic ObstructiveAdultHealth Care CostsHospitalizationHumansPatient DischargeRetrospective StudiesUnited States

Identifiers

PMID36427341
PMCPMC10372961
OpenAlexW4310048673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.